Share

    


In This Section

Home / Advocate / Letters and Statements

Letters and Statements

ACCC writes and signs on to letters to Congress and the Administration to promote our policy interests. We also write advocacy statements, blog posts, and opinion pieces on a wide range of topics in cancer care. Questions related to health policy? Contact Nicole Tapay, JD, Director, Cancer Care Delivery & Health or Meagan O’Neill, MS, Executive Director of ACCC.

Follow ACCC (@ACCCBuzz) on Twitter for late-breaking cancer policy news and announcements.

Latest Letters

  • ACCC Writes Letter to the House Committee of Ways and Means in Its Continued Support of H.R. 2407
    September 17, 2025

    In response to the overwhelming bipartisan momentum and committee action this week, ACCC submitted a new letter in strong support of H.R. 842, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act.
    Read the Letter

  • ACCC Submits Letters to the Centers for Medicare and Medicaid Services (CMS) on PFS and OPPS Regulations
    September 23, 2024

    On September 9, 2024, ACCC submitted comment letters to the Centers for Medicare and Medicaid Services (CMS) on the proposed physician fee schedule (PFS) and hospital outpatient prospective payment system (OPPS) regulations. Among other topics, ACCC asked CMS to remain open to discuss any issues that arise with implementation of the principal illness navigation (PIN) codes and other codes to reimburse for patient navigation services. ACCC also supported the proposed add-on payment for high-cost drugs delivered in the hospital outpatient departments of Indian Health Service (IHS) hospitals and tribal hospitals.
    PFS Letter OPPS Letter 

  • ACCC Writes Letter to the House Committee of Ways and Means in Support of H.R. 2407
    June 28, 2024

    ACCC joined over 500 organizations nationwide writing in support of the bipartisan Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407). ACCC members are all too familiar with the toll cancer takes on patients when diagnosed at a late stage. Early detection and treatment are crucial for improving cancer outcomes and saving lives.

    ACCC is very happy to learn that the legislation passed unanimously out of the House Ways and Means Committee on June 27, 2024.
    Read the Letter

  • ACCC Signs Letter in Support of the Reducing Hereditary Cancer Act
    March 21, 2023

    ACCC joins a broad coalition of patients, advocacy organizations, cancer centers, and healthcare professionals to express support for the Reducing Hereditary Cancer Act. This crucial piece of legislation would address unacceptable care gaps in Medicare beneficiary access to genetic testing for hereditary cancer risk, evidence-based screening, and risk-reducing interventions, when medically necessary and appropriate.
    Read the Letter

  • ACCC Asks Congress to Improve Access to Genetic Counselors in End-of-Year Package
    November 28, 2022

    ACCC joined more than 250 organizations in asking congressional leadership to include the Access to Genetic Counselor Services Act (S. 1450/H.R. 2144) in an end-of-year legislative package. This piece of legislation would allow the Medicare program to directly reimburse genetic counselors, improving Medicare beneficiary access to comprehensive genetic counseling services.
    Read the Letter